Cabaletta Bio Inc (NASDAQ: CABA) kicked off on Tuesday, down -3.66% from the previous trading day, before settling in for the closing price of $1.64. Over the past 52 weeks, CABA has traded in a range of $0.99-$7.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.35% over the last five years. While this was happening, its average annual earnings per share was recorded -5.33%. With a float of $81.83 million, this company’s outstanding shares have now reached $89.94 million.
The firm has a total of 161 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cabaletta Bio Inc (CABA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cabaletta Bio Inc is 9.03%, while institutional ownership is 43.47%.
Cabaletta Bio Inc (CABA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.54% during the next five years compared to -20.35% drop over the previous five years of trading.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Take a look at Cabaletta Bio Inc’s (CABA) current performance indicators. Last quarter, stock had a quick ratio of 3.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.54, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.26 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Analysing the last 5-days average volume posted by the [Cabaletta Bio Inc, CABA], we can find that recorded value of 1.1 million was lower than the volume posted last year of 1.6 million. As of the previous 9 days, the stock’s Stochastic %D was 63.33%.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 36.88%, which indicates a significant decrease from 42.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1064 in the past 14 days, which was lower than the 0.1506 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7757, while its 200-day Moving Average is $2.3454. Now, the first resistance to watch is $1.6433. This is followed by the second major resistance level at $1.7067. The third major resistance level sits at $1.7383. If the price goes on to break the first support level at $1.5483, it is likely to go to the next support level at $1.5167. Should the price break the second support level, the third support level stands at $1.4533.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
The company with the Market Capitalisation of 142.11 million has total of 50,743K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -115,860 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -35,940 K.
